Navidea Biopharmaceuticals Inc (NYSE MKT LLC:NAVB)

1.62
Delayed Data
As of Feb 27
 -0.05 / -2.99%
Today’s Change
0.97
Today|||52-Week Range
2.12
-14.29%
Year-to-Date
No recent news for Navidea Biopharmaceuticals Inc.

Today’s Trading

Previous close1.67
Today’s open1.66
Day’s range1.62 - 1.66
Volume267,098
Average volume (3 months)1,034,239
Market cap$244.2M
Dividend yield--
Data as of 4:07pm ET, 02/27/2015

Growth & Valuation

Earnings growth (last year)-18.72%
Earnings growth (this year)+30.00%
Earnings growth (next 5 years)--
Revenue growth (last year)+1,335.94%
P/E ratioNM
Price/Sales223.01
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ECYTEndocyte Inc-0.11-1.86%
OCATOcata Therapeutics I...-0.08-1.10%
VTAEVitae Pharmaceutical...-1.66-12.50%
EPRSEPIRUS Biopharmaceut...+0.43+4.26%
Data as of 4:00pm ET, 02/27/2015

Financials

Next reporting dateMarch 5, 2015
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$1.1M
Annual profit (last year)-$42.7M
Net profit margin-3,776.61%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ricardo J. Gonzalez
CFO, Secretary, Treasurer &
Executive VP
Brent L. Larson
Corporate headquarters
Dublin, Ohio

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account